We are live on ! Find out more
Qube Research & Technologies (QRT)

Qube Research & Technologies (QRT) Portfolio holdings

AUM $89.9B
1-Year Est. Return 20.22%
This Fund
S&P 500
This Quarter Est. Return
-4.58%
1 Year Est. Return
+20.22%
3 Year Est. Return
+42.42%
5 Year Est. Return
+23.97%
10 Year Est. Return
AUM
$38.3B
AUM Growth
+$10.8B
Cap. Flow
+$12.9B
Cap. Flow %
33.6%
Top 10 Hldgs %
9.4%
Holding
4,435
New
2,018
Increased
1,007
Reduced
916
Closed
371

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$302M
2
ADBE icon
Adobe
ADBE
+$291M
3
AMZN icon
Amazon
AMZN
+$266M
4
MSFT icon
Microsoft
MSFT
+$257M
5
LLY icon
Eli Lilly
LLY
+$214M

Sector Composition

Rank Sector Weight
1 Technology 19.59%
2 Consumer Discretionary 12.46%
3 Financials 10.63%
4 Industrials 10.62%
5 Healthcare 10.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NMRD
4001
DELISTED
Nemaura Medical, Inc. Common Stock
NMRD
$3 ﹤0.01%
+8
New +$6
SFT
4002
DELISTED
Shift Technologies, Inc. Class A Common Stock
SFT
$3 ﹤0.01%
+2
New +$3
RYM
4003
RYTHM Inc
RYM
$42.5M
0
BBGI icon
4004
Beasley Broadcasting Group
BBGI
$38M
0
BOLT icon
4005
Bolt Biotherapeutics
BOLT
$7.72M
0
CTSO icon
4006
Cytosorbents Corp
CTSO
$23.5M
$2 ﹤0.01%
+1
New +$3
ENLV icon
4007
Enlivex Ltd
ENLV
$69.2M
0
FBRX icon
4008
Forte Biosciences
FBRX
$1.56B
0
GAN
4009
DELISTED
GAN Ltd
GAN
$2 ﹤0.01%
+2
New +$3
HOOK
4010
DELISTED
HOOKIPA Pharma
HOOK
0
KXIN icon
4011
Kaixin Holdings
KXIN
$8.8M
0
SPCB icon
4012
SuperCom
SPCB
$68M
0
STRM
4013
DELISTED
Streamline Health Solutions
STRM
0
TNXP icon
4014
Tonix Pharmaceuticals
TNXP
$167M
0
TTNP
4015
DELISTED
Titan Pharmaceuticals
TTNP
0
VANI icon
4016
Vivani Medical
VANI
$110M
$2 ﹤0.01%
+2
New +$2
WATT icon
4017
Energous
WATT
$80.6M
0
YJ
4018
Yunji
YJ
$6.55M
$2 ﹤0.01%
+1
New +$4
ABTC
4019
American Bitcoin Corp
ABTC
$432M
0
TRAW icon
4020
Traws Pharma
TRAW
$7.74M
0
VIRX
4021
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$2 ﹤0.01%
+2
New +$3
CNTG
4022
DELISTED
Centogene N.V. Common Shares
CNTG
$2 ﹤0.01%
+2
New +$2
TRVN
4023
DELISTED
Trevena, Inc.
TRVN
0
BFX
4024
DELISTED
BowFlex Inc.
BFX
$2 ﹤0.01%
+2
New +$2
SFE
4025
DELISTED
Safeguard Scientifics, Inc.
SFE
$2 ﹤0.01%
+2
New +$3

Similar funds

Qube Research & Technologies (QRT)'s Q3 2023 Portfolio in Review

As of Q3 2023, Qube Research & Technologies (QRT) held 4,435 positions worth $38.3B, up 39% from $27.5B the previous quarter. Its ten largest holdings account for 9.4% of the portfolio.

Qube Research & Technologies (QRT) deployed $12.9B of net new capital in Q3 2023, opening 2,018 new positions and adding to 1,007 existing holdings. Its largest new stake was Eli Lilly: 415,473 shares worth $223M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Alphabet (Google) Class C, an estimated $192M trimmed.

  • Qube Research & Technologies (QRT)'s largest Q3 2023 buy was Eli Lilly: 415,473 shares worth $223M.
  • Qube Research & Technologies (QRT) added most to Johnson & Johnson in Q3 2023, an estimated $302M increase.
  • Qube Research & Technologies (QRT)'s biggest Q3 2023 reduction was Alphabet (Google) Class C, cutting an estimated $192M.
  • Qube Research & Technologies (QRT) fully exited Walt Disney in Q3 2023, selling an estimated $134M.
  • Qube Research & Technologies (QRT)'s ten largest holdings make up 9.4% of its $38.3B portfolio in Q3 2023.
  • Qube Research & Technologies (QRT) opened 2,018 new positions and closed 371 in Q3 2023.
  • Qube Research & Technologies (QRT)'s portfolio value rose 39% quarter-over-quarter to $38.3B.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2023, filed 13 Nov 2023.